doi:10.3969/j.issn.1004-583X.2021.05.015

Abstract

CLC Number:

R541.4

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.05.015

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I5/462

References 35

[1]	Ebadi N, Ghafouri-Fard S, Taheri M, et al. Dysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients[J]. Eur J Pharmacol, 2020, 867:172852. doi: 10.1016/j.ejphar.2019.172852 URL
[2]	Cao Q, Guo Z, Yan Y, et al. Exosomal long noncoding RNAs in aging and age-related diseases[J]. IUBMB Life, 2019, 71(12):1846-1856. doi: 10.1002/iub.v71.12 URL
[3]	Sallam T, Sandhu J, Tontonoz P. Long noncoding RNA discovery in cardiovascular disease: Decoding form to function[J]. Circ Res, 2018, 122(1):155-166. doi: 10.1161/CIRCRESAHA.117.311802 pmid: 29301847
[4]	Gong YP, Zhang YW, Su XQ, et al. Inhibition of long noncoding RNA MALAT1 suppresses high glucose-induced apoptosis and inflammation in human umbilical vein endothelial cells by suppressing the NF-κB signaling pathway[J]. Biochem Cell Biol, 2020, 98(6):669-675. doi: 10.1139/bcb-2019-0403 URL
[5]	Chen L, Hu L, Zhu X, et al. MALAT1 overexpression attenuates AS by inhibiting ox-LDL-stimulated dendritic cell maturation via miR-155-5p/NFIA axis[J]. Cell Cycle, 2020, 19(19):2472-2485. doi: 10.1080/15384101.2020.1807094 URL
[6]	Hu Y, Hu J. Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters[J]. Braz J Med Biol Res, 2019, 52(8):e8309. doi: 10.1590/1414-431x20198309 URL
[7]	Liu X, Li S, Yang Y, et al. The lncRNA ANRIL regulates endothelial dysfunction by targeting the let-7b/TGF-βR1 signalling pathway[J]. J Cell Physiol, 2021, 236(3):2058-2069. doi: 10.1002/jcp.v236.3 URL
[8]	Wang M, Liu Y, Li C, et al. Long noncoding RNA OIP5-AS1 accelerates the ox-LDL mediated vascular endothelial cells apoptosis through targeting GSK-3β via recruiting EZH2[J]. Am J Transl Res, 2019, 11(3):1827-1834.
[9]	Zhang C, Yang H, Li Y, et al. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis[J]. Mol Cell Biochem, 2020, 467(1-2):15-25. doi: 10.1007/s11010-020-03688-9 URL
[10]	Wu Z, He Y, Li D, et al. Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21[J]. Am J Transl Res, 2017, 9(7):3326-3335.
[11]	Jarinova O, Stewart AF, Roberts R, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus[J]. Arterioscler Thromb Vasc Biol, 2009, 29(10):1671-1677. doi: 10.1161/ATVBAHA.109.189522 pmid: 19592466
[12]	Cho H, Li Y, Archacki S, et al. Splice variants of lncRNA RNA ANRIL exert opposing effects on endothelial cell activities associated with coronary artery disease[J]. RNA Biol, 2020, 17(10):1391-1401. doi: 10.1080/15476286.2020.1771519 URL
[13]	Zhang Z, Gao W, Long QQ, et al. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population[J]. Sci Rep, 2017, 7(1):7491. doi: 10.1038/s41598-017-07611-z pmid: 28790415
[14]	Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs[J]. Mol Cell, 2013, 52(1):101-112. doi: 10.1016/j.molcel.2013.08.027 URL
[15]	Kino T, Hurt DE, Ichijo T, et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor[J]. Sci Signal, 2010, 3(107): ra8.
[16]	Li H, Liu Huang J, et al. Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population[J]. J Clin Lab Anal, 2020, 34(10):e23430.
[17]	Chen J, Dang J. LncRNA CASC11 was downregulated in coronary artery disease and inhibits transforming growth factor-β1[J]. J Int Med Res, 2020, 48(3):300060519889187.
[18]	Chen ZL, Chen YX, Zhou J, et al. LncRNA HULC alleviates HUVEC inflammation and improves angiogenesis after myocardial infarction through down-regulating miR-29b[J]. Eur Rev Med Pharmacol Sci, 2020, 24(11):6288-6298.
[19]	Li X, Dai Y, Yan S, et al. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction[J]. Biochem Biophys Res Commun, 2017, 491(4):1026-1033. doi: 10.1016/j.bbrc.2017.08.005 URL
[20]	Liao B, Dong S, Xu Z, et al. LncRNA Kcnq1ot1 renders cardiomyocytes apoptosis in acute myocardial infarction model by up-regulating Tead1[J]. Life Sci, 2020, 256:117811. doi: 10.1016/j.lfs.2020.117811 URL
[21]	Lin B, Xu J, Wang F, et al. LncRNA XIST promotes myocardial infarction by regulating FOS through targeting miR-101a-3p[J]. Aging (Albany NY), 2020, 12(8):7232-7247.
[22]	Vausort M, Wagner DR, Devaux Y. Long noncoding RNAs in patients with acute myocardial infarction[J]. Circ Res, 2014, 115(7):668-677. doi: 10.1161/CIRCRESAHA.115.303836 URL
[23]	Ma R, He X, Zhu X, et al. Promoter polymorphisms in the lncRNA-MIAT gene associated with acute myocardial infarction in Chinese Han population: A case-control study[J]. Biosci Rep, 2020, 40(2): BSR20191203.
[24]	Greco S, Zaccagnini G, Perfetti A, et al. Long noncoding RNA dysregulation in ischemic heart failure[J]. J Transl Med, 2016, 14(1):183. doi: 10.1186/s12967-016-0926-5 URL
[25]	Ou Y, Liao C, Li H, et al. LncRNA SOX2OT/Smad3 feedback loop promotes myocardial fibrosis in heart failure[J]. IUBMB Life, 2020, 72(11):2469-2480. doi: 10.1002/iub.v72.11 URL
[26]	Sama RR, Ward CL, Bosco DA. Functions of FUS/TLS from DNA repair to stress response: Implications for ALS[J]. ASN Neuro, 2014, 6(4):1759091414544472.
[27]	Lai L, Xu Y, Kang L, et al. LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure[J]. Exp Mol Pathol, 2020, 115:104480. doi: 10.1016/j.yexmp.2020.104480 URL
[28]	Li T, Qian D, Guoyan J, et al. Downregulated long noncoding RNA LUCAT1 inhibited proliferation and promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in chronic heart failure[J]. Eur Rev Med Pharmacol Sci, 2020, 24(1):385-395.
[29]	Yin Y, Yang ZF, Li XH, et al. Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2[J]. Eur Rev Med Pharmacol Sci, 2019, 23(19):8560-8565.
[30]	Deng H, Ouyang W, Zhang L, et al. LncRNA GASL1 is downregulated in chronic heart failure and regulates cardiomyocyte apoptosis[J]. Cell Mol Biol Lett, 2019, 24:41. doi: 10.1186/s11658-019-0165-x URL
[31]	李香梅, 卡地尔·依米提, 宋宁, 等. 外周血长链非编码RNA ENST00000589524.1表达水平与稳定型心绞痛相关性研究[J]. 新疆医科大学学报, 2019, 42(6):711-714.
[32]	宋宁. 长链非编码RNA(ENST00000418539.1)在稳定性冠心病患者单核细胞中表达水平的研究[D]. 新疆医科大学, 2017.
[33]	Galassi AR, Werner GS, Boukhris M, et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club[J]. EuroIntervention, 2019, 15(2):198-208. doi: 10.4244/EIJ-D-18-00826 URL
[34]	Peng W, Feng J. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma[J]. Biomed Pharmacother, 2016, 77:65-71. doi: 10.1016/j.biopha.2015.12.001 pmid: 26796267
[35]	Lu W, Sheng Z, Zhang Z, et al. LncRNA-LUNAR1 levels are closely related to coronary collaterals in patients with chronic total coronary occlusion[J]. J Cardiovasc Transl Res, 2020, 13(2):171-180. doi: 10.1007/s12265-019-09917-x URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 35

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Huang Yuling, Zhang Xinyue, Rong Pingping, Yang Wenqi, Cao Xinying, Xing Cainai, Wang Zhijun, Liu Ning. Correlation analysis of Non-HDL-C/HDL-C and NHR with the severity of coronary artery disease [J]. Clinical Focus, 2024, 39(2): 115-120.
[2]	. [J]. Clinical Focus, 2024, 39(1): 80-83.
[3]	Wang Jiaqi, Xie Yuetao, Gao Man, Song Xuelian, Zhang Feifei, Dang Yi, Qi Xiaoyong. Treatment of variant angina pectoris guided by the optical coherence tomography: A case report and literature review [J]. Clinical Focus, 2023, 38(10): 917-921.
[4]	Yang Changlin, Cao Shufeng, Qiao Lian, Zhao Huimin. Type I Kounis syndrome caused by drug allergy: A case report [J]. Clinical Focus, 2023, 38(10): 922-925.
[5]	Wei Yuhan, Zhao Yanan, Zhang Guibin, Wu Yuqing, Dong Bohua, Hu Jiayuan, Yang Wenqi. Correlation analysis of monocyte-to-high density lipoprotein cholesterol ratio, red cell distribution width, and uric acid with the severity of coronary artery disease in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(9): 796-801.
[6]	Li Hua, Chen Jianjun, Wei Jitao, Zhang Qi. Correlation between serum cystatin C level and nonobstructive coronary artery disease [J]. Clinical Focus, 2023, 38(9): 802-805.
[7]	Zhang Shangshi, Zhu Hongyan, Li Nan, Chen Yingxi. Correlation between coronary artery lesion and insulin resistance in patients with coronary heart disease combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 46-49.
[8]	Yi Xin, Liu Canzhang, Liu Qiang, Wang Cong, Gao Teng, Yan Jie. Effects of anxiety and depression on the composition and properties of coronary plaque in patients with coronary heart disease [J]. Clinical Focus, 2023, 38(1): 50-54.
[9]	Wang Yajie, Li Jianming, Liu Jingjing, Lu Yujie, Lin Wenhua. Predictor analysis of abnormal coronary flow reserve in women with non-obstructive coronary artery disease [J]. Clinical Focus, 2022, 37(9): 791-795.
[10]	Zhu Jun, Liu Yue, Chen Shuxia, Wang Xian, Zheng Luyan, Gu Jian. Predictive value of ApoB/ApoA1 ratio on the extent of coronary artery disease in patients with unstable angina pectoris [J]. Clinical Focus, 2022, 37(5): 422-426.
[11]	Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie. The relationship between serum homocysteine levels and SYNTAX score in patients with non-ST-segment elevation myocardial infarction [J]. Clinical Focus, 2022, 37(4): 325-328.
[12]	Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen. Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis [J]. Clinical Focus, 2022, 37(2): 101-105.
[13]	Duan Liqin. Relationship between clinical features, peripheral microcirculatory and severity of coronary artery disease in patients with coronary heart disease [J]. Clinical Focus, 2022, 37(2): 119-123.
[14]	Chen Xi, Jiang Shan. Correlation analysis between neutrophil percentage-to-albumin ratio and degree of coronary artery stenosis [J]. Clinical Focus, 2022, 37(1): 26-29.
[15]	Zhao Weifeng, Ma Chunyu. Correlation between 25-(OH)D₃ and degree of coronary artery stenosis in patients with coronary heart disease [J]. Clinical Focus, 2021, 36(11): 981-985.